x

Search for a diagnostic test

* (*) mandatory field

73 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

GERMANY

Bayern
MARTINSRIED

Accreditation Molecular diagnosis of familial malignant melanoma (CDKN2A gene)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of familial melanoma (CDKN2A, POT1 genes)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SWITZERLAND

Suisse Romande
GENÈVE

Accreditation Molecular diagnosis of familial melanoma (CDKN2A gene sequencing)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Bayern
REGENSBURG

Accreditation Molecular diagnosis of familial malignant melanoma (CDKN2A gene)
Universitätsklinikum Regensburg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
BELGIUM

OOST-VLAANDEREN
GENT

Accreditation Molecular diagnosis of familial malignant melanoma (CDKN2A gene)
Center for Medical Genetics Gent
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Baden-Württemberg
FREIBURG

Accreditation Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDKN2A and CDK4 gene)
Praxis für Humangenetik Freiburg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
MANNHEIM

Accreditation Molecular diagnosis of familial melanoma (CDKN2A and CDK4 gene)
Zentrum für Humangenetik Mannheim
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Accreditation Molecular diagnosis of familial malignant melanoma (CDKN2A gene)
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Comunidad Valenciana
ELCHE

Accreditation Diagnosis of the familial melanoma (CDKN2A gene)
Hospital General Universitario de Elche
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation Molecular diagnosis of Familial melanoma (CDKN2A gene (p16, p14-ARF))
University Hospitals Leuven - Gasthuisberg
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES

Accreditation Molecular diagnosis of Familial malignant melanoma (CDKN2A)
Université Catholique de Louvain - UCL
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
AUSTRIA

STEIERMARK
GRAZ

Accreditation Molecular diagnosis of familial malignant melanoma (CDKN2A, CDKN2B, CDKN2D, and CDK4 genes)
Medizinische Universität Graz
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDKN2A and CDK4 gene)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of rare skin tumor or harmatoma (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDK4, CDKN2A genes)
Pränatalmedizin München
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
WÜRZBURG

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
BAD STEBEN

Accreditation Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDKN2A and CDK4 gene)
Institut für angewandte Humangenetik und Onkogenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
UNITED KINGDOM

West Yorkshire
LEEDS

Accreditation Molecular diagnosis of Familial Melanoma (Sequence analysis of CDKN2a (exons 1alpha, 1beta, 2, 3) and CDK4 (exon 2)
St James's University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
CANADA

Ontario
LONDON

Accreditation Molecular Diagnosis of Hereditary Cancer Predisposition - Comprehensive NGS Panel (25 genes)
London Health Sciences Centre
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular diagnosis of susceptibility to malignant melanoma-5 (MC1R gene)
CeGaT GmbH
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
AUSTRIA

WIEN
WIEN

Accreditation Molecular diagnosis of familial melanoma (CDKN2A, CDK4, MC1R, and MITF genes)
Medizinische Universität Wien
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : Sanger sequencing, PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
VILLEJUIF

Diagnosis of predisposition to familial melanoma (CDKN2A/p14ARF, CDK4, MTIF and MC1R genes)
CLCC Institut Gustave Roussy
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of familial melanoma (Panel)
CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of familial melanoma (CDK4, CDKN2A, MC1R genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Aragón
ZARAGOZA

Molecular diagnosis of familial melanoma (CDKN2A gene / mutations in the coding regions and exon-intron boundaries)
Centro de Análisis Genéticos
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of familial melanoma (CDK4, CDKN2A gene)
Centro de Diagnóstico Biomédico - CDB
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
ITALY

LIGURIA
GENOVA

Molecular diagnosis of familial melanoma (CDKN2A,CDK4 genes)
IRCCS AOU San Martino - IST - DIMI
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Comunidad Valenciana
PATERNA

Diagnosis of familial melanoma (CDKN2A gene)
Sistemas Genómicos S.L.
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), MLPA based techniques

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of familial melanoma (CDKN2A and CDK4 gene)
Instituto Português de Oncologia do Porto, EPE / IPOFG - CRO Porto
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

TOSCANA
PISA

Molecular diagnosis of familial melanoma (CDK4, CDKN2A genes)
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
ITALY

PIEMONTE
TORINO

Molecular diagnosis of familial melanoma (CDKN2A, p14Arf, CDK4 genes)
A.O. Città della Salute e della Scienza di Torino - Ospedale Molinette
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of familial melanoma (CDKN2A gene)
Laboratorio Genoma
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Niedersachsen
OSNABRÜCK

Molecular diagnosis of familial malignant melanoma (CDKN2A gene)
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
STUTTGART

Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDKN2A gene)
Praxis für Humangenetik und Prävention
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
TURKEY

TURKEY
ISTANBUL

Molecular diagnosis of predisposition to familial melanoma (CDKN2A gene)
Genetiks - Genetic diagnosis and research center
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
POLAND

Warszawa
WARSAW

Molecular diagnosis of familial melanoma (CDKN2A gene)
NZOZ GENOMED
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

TOSCANA
PISA

Molecular diagnosis of familial adenomatous polyposis (APC, MUTYH genes)
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of familial malignant melanoma (CDKN2A gene: sequencing, MLPA)
bio.logis Zentrum für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
SPAIN

Comunidad Valenciana
PATERNA

Molecular diagnosis of susceptibility to familial melanoma (CDK4 gene / entire coding sequence)
IMEGEN - Instituto de Medicina Genómica
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing, Whole Exome Sequencing (WES)

More information
GERMANY

Sachsen
DRESDEN

Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDKN2A and CDK4 gene: sequencing / MLPA)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
POLAND

Bydgoszcz
BYDGOSZCZ

Molecular diagnosis of familial melanoma (CDKN2A gene)
Szpital Uniwersytecki im. dr. Antoniego Jurasza
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : Sanger sequencing, PCR based techniques

More information
SPAIN

Galicia
SANTIAGO DE COMPOSTELA

Molecular diagnosis of familial melanoma (CDK4, CDKN2A genes)
CHUS - Complejo Hospitalario Universitario de Santiago
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
AUSTRIA

WIEN
WIEN

Molecular diagnosis of familial melanoma (CDKN2A and MITF genes)
Praxis für Humangenetik
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
POLAND

Warszawa
WARSAW

Molecular diagnosis of familial melanoma (CDKN2A gene)
MEDGEN
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Baden-Württemberg
STUTTGART

Molecular diagnosis of familial melanoma (CDKN2A, CDK4 genes)
Klinikum Stuttgart - Standort Olgahospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
ITALY

VENETO
PADOVA

Molecular diagnosis of familial melanoma (CDKN2A and CDK4 genes)
Istituto Oncologico Veneto IRCCS
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of familial melanoma (CDK4 gene: Sequencing of the entire codimg region)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Asturias
OVIEDO

Diagnosis of susceptibility to familial melanoma (CDKN2A gene)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
SPAIN

Andalucía
MÁLAGA

Molecular diagnosis of susceptibility to familial melanoma (CDK4 gene)
Genetaq
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
SPAIN

Cataluña
BARCELONA

Molecular diagnosis of susceptibility to familial melanoma (CDKN2A gene / exon 2)
Hospital del Mar
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
SPAIN

Madrid
MADRID

Molecular diagnosis of susceptibility to familial melanoma (CDKN2A gene)
INGEMM - Instituto de Genética Médica y Molecular (IdiPAZ)
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

ILE-DE-FRANCE
PARIS

Predisposition to tumors (melanoma, pancreas, kidney, breast-ovary, colon, skin cancers) (Panel)
CHU Paris Nord-Val de Seine - Hôpital Xavier Bichat-Claude Bernard
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Comunidad Valenciana
ELCHE

Diagnosis of major susceptibility to familial melanoma (CDK4, CDKN2A genes)
Bioarray
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of susceptibility to familial melanoma (CDK4, CDKN2A and CDKN2B genes)
DNA Data
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
CANADA

Alberta
CALGARY

Molecular Diagnosis of Hereditary Skin Cancer NGS Panel (6 genes)
Alberta Children's Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques, MLPA based techniques, Array based techniques

More information
GERMANY

Sachsen
DRESDEN

Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

ILE-DE-FRANCE
VILLEJUIF

Diagnosis of tumors (Panel)
CLCC Institut Gustave Roussy
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
AUSTRIA

WIEN
WIEN

Molecular diagnosis of familial melanoma (CDKN2A gene)
Medizinische Universität Wien
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
ITALY

TOSCANA
FIRENZE

Molecular diagnosis of familial melanoma (CDKN2A and CDK4 genes)
Azienda Ospedaliero Universitaria Careggi - NEUROFARBA
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Diagnosis of skin tumors (dermoscopy, ultrasound, histology and if applicable molecular analysis)
Zentrum für Dermatoonkologie am Universitätsklinikum Tübingen
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics, Pathology

More information
CZECH REPUBLIC

South Moravia
BRNO

Molecular diagnosis of familial melanoma (CDKN2A gene)
Masaryk Memorial Cancer Institute
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Madrid
SAN SEBASTIÁN DE LOS REYES

Diagnosis of familial melanoma (MC1R, CDKN2A/p16 and CDK4/exon 2)
Laboratorio de Genética Clínica, S.L.
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
SPAIN

Madrid
MADRID

Molecular diagnosis of familial melanoma and melanoma-pancreatic cancer syndrome (CDKN2A gene)
Centro Nacional de Investigaciones Oncológicas (CNIO)
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
GERMANY

Bayern
MÜNCHEN

Molecular diagnosis of familial melanoma / melanoma-pancreatic cancer syndrome (CDKN2A and CDK4 gene)
Institut für Humangenetik der LMU-München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Madrid
MAJADAHONDA

Molecular diagnosis of familial melanoma (sequencing of CDKN2A gene)
Genyca Innova
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of predisposition to familial melanoma (CDKN2A, CDK4 genes)
USI - Unione Sanitaria Internazionale
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
GERMANY

Berlin
BERLIN

Molecular diagnosis of cancer (NGS Cancer Panel)
ATG GenMed GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Andalucía
CÁDIZ

Molecular diagnosis of familial melanoma (CDKN2A gene)
Hospital Universitario Puerta del Mar
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
SPAIN

Andalucía
SEVILLA

Diagnosis of selection of therapeutic options for familial melanoma (BRAF gene)
Hospital Universitario Virgen del Rocío
Purpose(s) : Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
ITALY

EMILIA ROMAGNA
MELDOLA

Molecular diagnosis of familial melanoma (hTERT mutation analysis)
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
HUNGARY

Dél-Alföld
SZEGED

Familial melanoma syndrome
University of Szeged Deparment of Medical Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information